SynthesisCardiovascular diabetology2016

Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.

Christian Sonesson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.